葛蘭素史克 GSK 深 滬
等待開盤 06-25 09:30:00 美东时间
51.10
-0.970
-1.86%
華盛通- 最 高52.20
- 今 開52.15
- 成交量 332.89万股
- 最 低 51.015
- 昨 收 52.07
- 總市值 1023.97亿
- 52周最高 60.7713
- 市盈率 靜 13.96
- 換手率 0.17%
- 52周最低 33.6782
- 委 比 89.27%
- 總股本 20.04亿
- 歷史最高 60.7713
- 量 比 0.88
- 振 幅 2.28%
- 歷史最低 8.5235
- 每 手 1
- 風險率 7.16%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多GSK Discloses Executive Notional ADS Acquisition by U.S. President
GlaxoSmithKline ( ($GB:GSK) ) has shared an update. GSK has disclosed a transac...
06-24 22:32
GSK launches $124-per-share tender offer to acquire oncology developer Nuvalent
GlaxoSmithKline ( ($GB:GSK) ) just unveiled an update. GSK has launched a cash ...
06-24 21:58
GSK board members boost holdings with coordinated share purchases
An update from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK has disclose...
06-23 23:07
美股异动 | mRNA流感疫苗叩响FDA大门！疫苗股全线走高，莫德纳大涨6%，默沙东、阿斯利康、葛兰素史克、强生均涨约2%
mRNA流感疫苗叩响FDA大门！疫苗股全线走高，莫德纳大涨6%，默沙东、阿斯利康、葛兰素史克、强生均涨约2%>>
06-23 22:58
如何破局biotech“科举式”内卷：GSK百亿美金收购启示录
（来源：新康界） 转自：新康界 在过去的几年里，中国创新药行业内部正悄然蔓延着一种心照不宣的集体幻觉：“下一个创造百亿美元神话的‘K药’（帕博利珠单抗），一定会...
06-22 17:45
GSK Targets Relapsed B-Cell Lymphoma With New Early-Stage Trial
GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The...
06-19 00:36
期权扫描 | 看涨情绪主导！SpaceX期权首日成交跻身TOP3，海量Call单押注股价走高；微软看涨占比超七成
看涨情绪主导！SpaceX期权首日成交跻身TOP3，海量Call单押注股价走高；30亿美元算力租约告吹！微软看涨占比仍超七成；获高管增持，SOFI期权成交活跃>>
06-17 15:40
维福峰会展望猎鹰项目及迈向以代理商为基础的生物制药行业之路
2026年5月28 - 29日，维福系统研发与质量峰会欧洲站在丹麦哥本哈根举行，超2000名临床、监管、安全和质量领域领导者参会，举行100多场会议。 维福系统...
06-15 15:20
葛兰素史克突破阻力：在行业强势中上涨2.63%，点燃看涨势头
葛兰素史克（GSK）股价盘中飙升2.63%，收于每股51.03美元，前一交易日收盘价49.72美元，盘中最高触及51.16美元，突破即时阻力位。 上涨原因是技术...
06-15 15:15
公司簡介
公司名稱
|
葛兰素史克
|
行業分類
|
制药
|
業務描述
|
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
|
GSK Discloses Executive Notional ADS Acquisition by U.S. President
GlaxoSmithKline ( ($GB:GSK) ) has shared an update. GSK has disclosed a transac...
06-24 22:32
GSK launches $124-per-share tender offer to acquire oncology developer Nuvalent
GlaxoSmithKline ( ($GB:GSK) ) just unveiled an update. GSK has launched a cash ...
06-24 21:58
GSK board members boost holdings with coordinated share purchases
An update from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK has disclose...
06-23 23:07
美股异动 | mRNA流感疫苗叩响FDA大门！疫苗股全线走高，莫德纳大涨6%，默沙东、阿斯利康、葛兰素史克、强生均涨约2%
mRNA流感疫苗叩响FDA大门！疫苗股全线走高，莫德纳大涨6%，默沙东、阿斯利康、葛兰素史克、强生均涨约2%>>
06-23 22:58
如何破局biotech“科举式”内卷：GSK百亿美金收购启示录
（来源：新康界） 转自：新康界 在过去的几年里，中国创新药行业内部正悄然蔓延着一种心照不宣的集体幻觉：“下一个创造百亿美元神话的‘K药’（帕博利珠单抗），一定会...
06-22 17:45
GSK Targets Relapsed B-Cell Lymphoma With New Early-Stage Trial
GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The...
06-19 00:36
期权扫描 | 看涨情绪主导！SpaceX期权首日成交跻身TOP3，海量Call单押注股价走高；微软看涨占比超七成
看涨情绪主导！SpaceX期权首日成交跻身TOP3，海量Call单押注股价走高；30亿美元算力租约告吹！微软看涨占比仍超七成；获高管增持，SOFI期权成交活跃>>
06-17 15:40
维福峰会展望猎鹰项目及迈向以代理商为基础的生物制药行业之路
2026年5月28 - 29日，维福系统研发与质量峰会欧洲站在丹麦哥本哈根举行，超2000名临床、监管、安全和质量领域领导者参会，举行100多场会议。 维福系统...
06-15 15:20
葛兰素史克突破阻力：在行业强势中上涨2.63%，点燃看涨势头
葛兰素史克（GSK）股价盘中飙升2.63%，收于每股51.03美元，前一交易日收盘价49.72美元，盘中最高触及51.16美元，突破即时阻力位。 上涨原因是技术...
06-15 15:15
派息除權日
|
每股總股息
| 派息日期 |
2026-05-15
|
0.45
|
2026-07-09
|
2026-02-20
|
0.48
|
2026-04-09
|
2025-11-14
|
0.41
|
2026-01-08
|
2025-08-15
|
0.42
|
2025-10-09
|
2025-05-16
|
0.42
|
2025-07-10
|
2025-02-21
|
0.39
|
2025-04-10
|
2024-11-15
|
0.38
|
2025-01-09
|
2024-08-16
|
0.38
|
2024-10-10
|
2024-05-16
|
0.37
|
2024-07-11
|
2024-02-22
|
0.40
|
2024-04-11
|
2023-11-16
|
0.33
|
2024-01-11
|
2023-08-17
|
0.35
|
2023-10-12
|
2023-05-18
|
0.34
|
2023-07-13
|
2023-02-23
|
0.33
|
2023-04-13
|
2022-11-17
|
0.31
|
2023-01-12
|
2022-08-18
|
0.38
|
2022-10-06
|
2022-05-19
|
0.34
|
2022-07-01
|
2022-02-24
|
0.61
|
2022-04-07
|
2021-11-18
|
0.52
|
2022-01-13
|
2021-08-19
|
0.52
|
2021-10-07
|
2021-05-20
|
0.52
|
2021-07-08
|
2021-02-18
|
0.62
|
2021-04-08
|
2020-11-12
|
0.49
|
2021-01-14
|
2020-08-13
|
0.48
|
2020-10-08
|
2020-05-14
|
0.46
|
2020-07-09
|
2020-02-20
|
0.59
|
2020-04-09
|
2019-11-14
|
0.48
|
2020-01-09
|
2019-08-08
|
0.46
|
2019-10-10
|
2019-05-16
|
0.47
|
2019-07-11
|
2019-02-21
|
0.59
|
2019-04-11
|
2018-11-15
|
0.48
|
2019-01-10
|
2018-08-09
|
0.49
|
2018-10-11
|
2018-05-10
|
0.50
|
2018-07-12
|
2018-02-22
|
0.65
|
2018-04-12
|
2017-11-09
|
0.51
|
2018-01-11
|
2017-08-09
|
0.50
|
2017-10-12
|
2017-05-10
|
0.49
|
2017-07-13
|
2017-02-22
|
0.57
|
2017-04-13
|
2016-11-02
|
0.46
|
2017-01-12
|
2016-08-10
|
0.46
|
2016-10-13
|
2016-05-11
|
0.50
|
2016-07-14
|
2016-02-17
|
1.22
|
2016-04-14
|
2015-11-10
|
0.54
|
2016-01-14
|
2015-08-12
|
0.57
|
2015-10-01
|
2015-05-13
|
0.58
|
2015-07-09
|
2015-02-18
|
0.70
|
2015-04-09
|
2014-11-05
|
0.61
|
2015-01-08
|
2014-08-06
|
0.65
|
2014-10-02
|
2014-05-14
|
0.64
|
2014-07-10
|
2014-02-19
|
0.75
|
2014-04-10
|
2013-11-13
|
0.62
|
2014-01-09
|
2013-08-07
|
0.55
|
2013-10-03
|
2013-05-08
|
0.55
|
2013-07-11
|
2013-02-20
|
0.69
|
2013-04-11
|
2012-11-14
|
0.58
|
2013-01-03
|
2012-08-08
|
0.53
|
2012-10-04
|
2012-05-09
|
0.55
|
2012-07-05
|
2012-02-15
|
0.82
|
2012-04-12
|
2011-11-02
|
0.54
|
2012-01-05
|
2011-08-03
|
0.52
|
2011-10-06
|
2011-05-04
|
0.53
|
2011-07-07
|
2011-02-09
|
0.62
|
2011-04-07
|
2010-10-27
|
0.51
|
2011-01-06
|
2010-07-28
|
0.46
|
2010-10-07
|
2010-05-05
|
0.46
|
2010-07-08
|
2010-02-10
|
0.57
|
2010-04-08
|
2009-11-04
|
0.49
|
2010-01-07
|
2009-07-29
|
0.46
|
2009-10-08
|
2009-04-29
|
0.41
|
2009-07-09
|
2009-02-11
|
0.49
|
2009-04-09
|
2008-10-29
|
0.47
|
2009-01-08
|
2008-07-30
|
0.52
|
2008-10-09
|
2008-04-30
|
0.52
|
2008-07-10
|
2008-02-13
|
0.63
|
2008-04-10
|
2007-10-31
|
0.53
|
2008-01-10
|
2007-08-01
|
0.49
|
2007-10-11
|
2007-05-02
|
0.48
|
2007-07-12
|
2007-02-14
|
0.55
|
2007-04-12
|
2006-11-01
|
0.45
|
2007-01-04
|
2006-08-02
|
0.41
|
2006-10-05
|
2006-05-10
|
0.39
|
2006-07-06
|
2006-02-15
|
0.49
|
2006-04-06
|
2005-11-02
|
0.36
|
2006-01-05
|
2005-08-03
|
0.35
|
2005-10-06
|
2005-05-11
|
0.38
|
2005-07-07
|
2005-02-16
|
0.44
|
2005-04-07
|
2004-11-03
|
0.37
|
2005-01-06
|
2004-08-04
|
0.37
|
2004-09-30
|
2004-05-12
|
0.35
|
2004-07-01
|
2004-02-18
|
0.52
|
2004-04-15
|
2003-10-29
|
0.30
|
2004-01-06
|
2003-07-30
|
0.29
|
2003-10-02
|
2003-05-07
|
0.29
|
2003-07-03
|
2003-02-19
|
0.42
|
2003-04-17
|
2002-10-30
|
0.28
|
2003-01-03
|
2002-07-31
|
0.28
|
2002-10-03
|
2002-05-01
|
0.26
|
2002-07-05
|
2002-02-20
|
0.34
|
2002-04-18
|
2001-10-31
|
0.26
|
2002-01-03
|
2001-08-01
|
0.25
|
2001-10-04
|
2001-05-02
|
0.26
|
2001-07-05
|
2000-12-27
|
0.66
|
2001-04-27
|
2000-08-09
|
0.43
|
2000-10-26
|
2000-03-01
|
0.65
|
2000-06-05
|
1999-08-11
|
0.49
|
1999-10-12
|
1999-03-03
|
0.68
|
1999-06-01
|
1998-08-12
|
0.51
|
1998-10-13
|
1998-03-04
|
0.65
|
1998-06-01
|
1997-08-13
|
0.48
|
1997-10-13
|
1997-03-19
|
0.50
|
1997-05-30
|
1996-08-16
|
0.50
|
1996-10-11
|
1996-03-22
|
0.48
|
1996-05-30
|
1995-09-22
|
0.67
|
1995-11-02
|
1995-02-24
|
0.34
|
1995-04-20
|
1994-09-23
|
0.60
|
1994-12-01
|
1994-03-14
|
0.28
|
1994-04-21
|
1993-09-24
|
0.47
|
1993-11-29
|
1993-03-05
|
0.23
|
1993-05-10
|
1992-09-21
|
0.38
|
1992-11-23
|
1992-02-28
|
0.24
|
1992-05-11
|
1982-05-12
|
0.09
|
1982-07-06
|
1981-11-20
|
0.16
|
1982-01-19
|
1981-05-18
|
0.08
|
1981-07-03
|
1980-11-21
|
0.17
|
1981-01-19
|
